Atlas Trials

Lanreotide In Polycystic Kidney Disease Study

Clinical trial NCT02127437 · COMPLETED

Trial details

NCT number
NCT02127437
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Autosomal Dominant Polycystic Kidney Disease (ADPKD
Start date
2014-09-19
Primary completion
2019-07-31
Enrollment
159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.